期刊文献+

冠心病中医证型与血浆vWF、Ps、hs-CRP、FIB、TXB_2、6-keto-PG_(1α)关系的临床研究 被引量:11

Clinical Research on Expression of v WF,Ps,hs-CRP,FIB,TXB_2,6-keto-PGF_(1α) of Differential TCM Syndrome of Coronary Heart Disease
下载PDF
导出
摘要 目的:探讨血浆v WF、Ps、hs-CRP、FIB、TXB2、6-keto-PGF1α与冠心病中医证型的关系。方法:将152例冠心病患者辨证分为心血瘀阻、痰阻心脉、阴寒凝滞、心肾阴虚、气阴两虚、阳气虚衰,测定血浆v WF、Ps、hs-CRP、FIB、TXB2、6-keto-PGF1α值。结果:心血瘀阻、痰阻心脉、心肾阴虚、气阴两虚4型血浆v WF、Ps、FIB、TXB2水平明显升高,心血瘀阻、痰阻心脉2型高于心肾阴虚、气阴两虚2型,心血瘀阻、痰阻心脉、心肾阴虚、气阴两虚4型血浆6-keto-PGF1α水平明显降低,心肾阴虚、气阴两虚证型2型低于心血瘀阻和痰阻心脉2型。各证型血浆hs-CRP水平比较差异无统计学意义。结论:提示心肾阴虚、气阴两虚两型病机为炎症损伤血管内皮,心血瘀阻、痰阻心脉是炎症损伤血管内皮基础上,抗血栓能力下降,导致动脉粥样硬化。 Objectives: To study relationship betweedrome types of coronary heart disease (CHD) and plasma vWF ( yon willebrand ' s factor), Ps ( P-selectRP ( hight-sensitivity C-reactive protein ), TXB2 (thromboxane B2 ), 6-keto-PGF1α (6-keto-prostaglandin), and guide the treatment based on syndrome differentiation of CHD. Methods: The patients with CHD w into 6 groups, such as stagnation of heart vessel, retention of phlegm in heart vessel, stagnation of qi due to dcieney of heart and kidney, deficieney of both qi and yin, deficieney of both yang and qi. Levels of plasma vWIRP,FIB, TXB2 , 6-keto-PGF1α were determinated. Results: Plasma vWF, Ps, FIB, TXB2 , hs-CRP levels of )f heart vessel group, retention of phlegm in heart vessel group, yin deficieney of heart and kidney group, deboth qi and yin group were significantly higher than that of control group respectively. Plasma 6-keto-PGF1α levour groups were also significantly lower than that of control group. Plasma vWF. Ps. FIB, TXB2 levels of stagnat vessel group, retention of phlegm in heart vessel group were statistically higher than those of yin deficieney kidney group, deficieney of both qi and yin group. Plasma 6-keto-PGF1α levels of yin deficieney of heart agroup, deficieney of both qi and yin group were significantly lower than those of stagnation of heart vessel lition of phlegm in heart vessel group. There was no statistical difference of plasma hs-CRP of four groups respeclusion : Two type of deficiency of both qi and yin of heart and kidney is primarily by endothelial cell function in y injury, blood stagnation and phlegm blocking heart vessel is based on the inflammatory injury of endothelial celthe antithrombotic capability of Ecs and promote the extent of atherosclerosis.
出处 《中国中医基础医学杂志》 CAS CSCD 北大核心 2015年第1期66-68,79,共4页 JOURNAL OF BASIC CHINESE MEDICINE
基金 山西省科技项目(0410789-1)-血浆同型半胱氨酸与冠心病中医证型的关系及致病机制研究 上海市教委资助项目(06CZ021)-银杏叶对高同型半胱氨酸血症内皮功能受损的干预作用及其机制实验研究
关键词 冠心病 中医证型 P-选择素 冯维尔布兰德因子 高敏C反应蛋白 纤维蛋白原 Coronary heart disease Syndrome differe'CM Von willebrand' s factor P-selectin Fibrinogen
  • 相关文献

参考文献12

  • 1Zingarelli B, Salzman AL, Szabo C. Genetic disruption of poly (AD P-ribose ) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-t in myocardial ischemia/ reperfusion injury [ J ]. Circ Re s, 1998, 83 ( 1 ) : 85-94.
  • 2胡高频,张文秀,李志梁.P-选择素与心肌缺血再灌注损伤[J].国外医学(心血管疾病分册),2001,28(1):26-29. 被引量:16
  • 3水华,杨成悌,辛楠.P-选择素在心血管疾病中的应用价值[J].心血管病学进展,2001,22(3):165-167. 被引量:24
  • 4Chen WS, Chen SJ, Lee CC, et al. Plasma P-selectin predicts long-term cardiovascular events in hospitalized patients with suspected coronary artery disease and preserved left ventricular function: a lO-year follow-up study [ J ]. Biomed J, 2013,36 (3) :137-143.
  • 5Briede JJ, Wielders SJ, Heemskerk JW, et al. Von WiUebrand factor stimulates thrombin induced exposure of procoagulant phos- pholipids on the surface of fibrin adherent platelets[ J]. J Thromb Haemost,2003,1 (3) :559-565.
  • 6Vanhoorelbeke K, Ulrichts H, Schoolmeester A, et al. Inhibition of platelet adhesion to collagen as a new target for antithrombotic drugs[J]. Curt Drug Targets Cardiovasc Haematol Disord,2003, 3(2) :125-140.
  • 7Rafai N, Ridker PM. High sensitivity C-reactive protien : a novel and promising marker of coronary heart disease [ J]. Clin Chem, 2001,47:403-411.
  • 8Ridker PM. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit[ J]. Am Heart J,2004,148 (1 Suppl) :S19-26.
  • 9Koenig W. Fibrinogen in cardiovascular disease: an update[ J]. Thromb Haemost, 2003,89(4) :601-609.
  • 10Orem C, Durmus I, Kilinc K, et al. Plasma fibronectin level and its association with coronary artery disease and carotid intimamedia thickness [ J ]. Coron Artery Dis,2003,14 ( 3 ) :219- 24.

二级参考文献13

  • 1陈骏,龚肖崎,张亚霏.细胞粘附分子的免疫学定量检测方法及其临床应用[J].国外医学(免疫学分册),1993,16(6):310-313. 被引量:2
  • 2Yu H,Biochemistry,2000年,33卷,8期,601页
  • 3Zingarelli B,Salzman AL,Szabo C. Circulation Research . 1998
  • 4Tomoda H,Aoki N. Angiology . 1998
  • 5Shimomura H,Ogawa H,Arai H,et al. The American Journal of Cardiology . 1998
  • 6Hansen PR. Circulation . 1995
  • 7Lefer AM,Weyrich AS,Buerke M. Cardiovascular Research . 1994
  • 8Polley MJ,Phillips ML,Wayner E,et al. Proceedings of the National Academy of Sciences of the United States of America . 1991
  • 9Weyrich AS,MaXY,Lefer DJ,et al. The Journal of Clinical Investigation . 1993
  • 10Lefer DJ,Flynn DM,Anderson DC,et al. American Journal of Physiology . 1996

共引文献238

同被引文献261

引证文献11

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部